quinazolines has been researched along with Death, Sudden in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyer, EC; Dudley, SC; Efimov, IR; Gemel, J; Greener, ID; Liu, H; Ng, FS; Rutledge, CA; Sergeyenko, AM; Sovari, AA; Sulkin, MS | 1 |
Chatterjee, K; Daly, PA; Kereiakes, D; Modin, G; Simonton, CA | 1 |
2 other study(ies) available for quinazolines and Death, Sudden
Article | Year |
---|---|
c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Benzodioxoles; Connexin 43; CSK Tyrosine-Protein Kinase; Death, Sudden; Echocardiography; Enzyme Inhibitors; Gap Junctions; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Protein Phosphatase 1; Quinazolines; Reactive Oxygen Species; src-Family Kinases | 2014 |
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Death, Sudden; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Milrinone; Pyridones; Quinazolines; Retrospective Studies; Time Factors | 1987 |